» Articles » PMID: 26300704

Selecting Rehabilitation Outcome Measures for People with Multiple Sclerosis

Overview
Journal Int J MS Care
Date 2015 Aug 25
PMID 26300704
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the well-known benefits of using standardized outcome measures (OMs) in clinical practice, a variety of barriers interfere with their use. In particular, rehabilitation therapists lack sufficient knowledge in selecting appropriate OMs. The challenge is compounded when working with people with multiple sclerosis (MS) owing to heterogeneity of the patient population and symptom variability in individual patients. To help overcome these barriers, the American Physical Therapy Association appointed the Multiple Sclerosis Outcome Measures Task Force to review and make evidence-based recommendations for OM use in clinical practice, education, and research specific to people with MS. Sixty-three OMs were reviewed based on their clinical utility, psychometric properties, and a consensus evaluation of the appropriateness of use for people with MS. We sought to illustrate use of the recommendations for two cases. The first case involves a 43-year-old man with new-onset problems after an exacerbation. The second case pertains to an outpatient clinic interested in assessing the effectiveness of their MS rehabilitation program. For each case, clinicians identified areas that were important to assess and various factors deemed important for OM selection. Criteria were established and used to assist in OM selection. In both cases, the described processes narrowed the selection of OMs and assisted with choosing the most appropriate ones. The recommendations, in addition to the processes described in these two cases, can be used by clinicians in any setting working with patients with MS across the disability spectrum.

Citing Articles

Virtual reality-based neuroproprioceptive physiotherapy in multiple sclerosis: a protocol for a double-arm randomised assessor-blinded controlled trial on upper extremity function, postural function and quality of life, with molecular and functional....

Miznerova B, Reissigova J, Vasa L, Frank J, Hudec M, Rodina L BMJ Open. 2025; 15(1):e088046.

PMID: 39788766 PMC: 11752059. DOI: 10.1136/bmjopen-2024-088046.


Fall risk is related to cognitive functioning in ambulatory multiple sclerosis patients.

Bilgin Y, Koskderelioglu A, Gedizlioglu M Neurol Sci. 2023; 44(9):3233-3242.

PMID: 36997775 DOI: 10.1007/s10072-023-06770-4.


Efficacy of Transcranial Direct Current Stimulation (tDCS) on Balance and Gait in Multiple Sclerosis Patients: A Machine Learning Approach.

Marotta N, de Sire A, Marinaro C, Moggio L, Inzitari M, Russo I J Clin Med. 2022; 11(12).

PMID: 35743575 PMC: 9224780. DOI: 10.3390/jcm11123505.


Protocol for an exploratory, longitudinal single case study of a novel palliative care rehabilitative service.

Ni Cheileachair F, Ni Cheileachair F, Johnston B, Payne C, Cahill F, Mannion L HRB Open Res. 2022; 4:131.

PMID: 35118229 PMC: 8790707. DOI: 10.12688/hrbopenres.13461.2.


Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working....

Roberts F, Hobbs H, Jessop H, Bozzolini C, Burman J, Greco R Front Neurol. 2020; 11:556141.

PMID: 33362684 PMC: 7759663. DOI: 10.3389/fneur.2020.556141.


References
1.
Newsome S, Wang J, Kang J, Calabresi P, Zackowski K . Quantitative measures detect sensory and motor impairments in multiple sclerosis. J Neurol Sci. 2011; 305(1-2):103-11. PMC: 3090542. DOI: 10.1016/j.jns.2011.03.003. View

2.
Vickrey B, Hays R, Harooni R, Myers L, Ellison G . A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995; 4(3):187-206. DOI: 10.1007/BF02260859. View

3.
Cella D, Dineen K, Arnason B, Reder A, Webster K, Karabatsos G . Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology. 1996; 47(1):129-39. DOI: 10.1212/wnl.47.1.129. View

4.
Fisk J, Ritvo P, Ross L, Haase D, Marrie T, Schlech W . Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994; 18 Suppl 1:S79-83. DOI: 10.1093/clinids/18.supplement_1.s79. View

5.
Potter K, Cohen E, Allen D, Bennett S, Brandfass K, Widener G . Outcome measures for individuals with multiple sclerosis: recommendations from the American Physical Therapy Association Neurology Section task force. Phys Ther. 2013; 94(5):593-608. DOI: 10.2522/ptj.20130149. View